WO2001066753A3 - Human genes and gene expression products - Google Patents

Human genes and gene expression products Download PDF

Info

Publication number
WO2001066753A3
WO2001066753A3 PCT/US2001/007787 US0107787W WO0166753A3 WO 2001066753 A3 WO2001066753 A3 WO 2001066753A3 US 0107787 W US0107787 W US 0107787W WO 0166753 A3 WO0166753 A3 WO 0166753A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
gene expression
expression products
human genes
polynucleotides
Prior art date
Application number
PCT/US2001/007787
Other languages
French (fr)
Other versions
WO2001066753A2 (en
Inventor
Lewis T Williams
Jaime Escobedo
Michael A Innis
Pablo Dominguez Garcia
Julie Sudduth-Klinger
Christoph Reinhard
Filippo Randazzo
Giulia C Kennedy
David Pot
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
William Lee Jones
Birgit Stache-Crain
Original Assignee
Chiron Corp
Hyseq Inc
Lewis T Williams
Jaime Escobedo
Michael A Innis
Pablo Dominguez Garcia
Julie Sudduth-Klinger
Christoph Reinhard
Filippo Randazzo
Giulia C Kennedy
David Pot
Altaf Kassam
George Lamson
Radoje Drmanac
Radomir Crkvenjakov
Mark Dickson
Snezana Drmanac
Ivan Labat
Dena Leshkowitz
David Kita
Veronica Garcia
William Lee Jones
Birgit Stache-Crain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp, Hyseq Inc, Lewis T Williams, Jaime Escobedo, Michael A Innis, Pablo Dominguez Garcia, Julie Sudduth-Klinger, Christoph Reinhard, Filippo Randazzo, Giulia C Kennedy, David Pot, Altaf Kassam, George Lamson, Radoje Drmanac, Radomir Crkvenjakov, Mark Dickson, Snezana Drmanac, Ivan Labat, Dena Leshkowitz, David Kita, Veronica Garcia, William Lee Jones, Birgit Stache-Crain filed Critical Chiron Corp
Priority to JP2001565907A priority Critical patent/JP2004502406A/en
Priority to AU2001245619A priority patent/AU2001245619A1/en
Priority to EP01918557A priority patent/EP1263956A2/en
Publication of WO2001066753A2 publication Critical patent/WO2001066753A2/en
Publication of WO2001066753A3 publication Critical patent/WO2001066753A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

This invention relates to novel human polynucleotides and variants thereof, their encoded polypeptides and variants thereof, to genes corresponding to these polynucleotides and to proteins expressed by the genes. The invention also relates to diagnostic and therapeutic agents employing such novel human polynucleotides, their corresponding genes or gene products, e.g., these genes and proteins, including probes, antisense constructs, and antibodies.
PCT/US2001/007787 2000-03-09 2001-03-09 Human genes and gene expression products WO2001066753A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2001565907A JP2004502406A (en) 2000-03-09 2001-03-09 Human genes and human gene expression products
AU2001245619A AU2001245619A1 (en) 2000-03-09 2001-03-09 Human genes and gene expression products
EP01918557A EP1263956A2 (en) 2000-03-09 2001-03-09 Human genes and gene expression products

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18860900P 2000-03-09 2000-03-09
US60/188,609 2000-03-09

Publications (2)

Publication Number Publication Date
WO2001066753A2 WO2001066753A2 (en) 2001-09-13
WO2001066753A3 true WO2001066753A3 (en) 2002-08-15

Family

ID=22693853

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/007787 WO2001066753A2 (en) 2000-03-09 2001-03-09 Human genes and gene expression products

Country Status (5)

Country Link
US (1) US20030044783A1 (en)
EP (1) EP1263956A2 (en)
JP (1) JP2004502406A (en)
AU (1) AU2001245619A1 (en)
WO (1) WO2001066753A2 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858386B1 (en) 1998-05-21 2005-02-22 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1131430B1 (en) * 1998-11-10 2007-01-17 Emory University Mitogenic regulators
US7700359B2 (en) * 2000-06-02 2010-04-20 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells
JP2004535765A (en) * 2000-12-07 2004-12-02 カイロン コーポレイション Endogenous retrovirus up-regulated in prostate cancer
US7601825B2 (en) 2001-03-05 2009-10-13 Agensys, Inc. Nucleic acid and corresponding protein entitled 121P1F1 useful in treatment and detection of cancer
US6924358B2 (en) 2001-03-05 2005-08-02 Agensys, Inc. 121P1F1: a tissue specific protein highly expressed in various cancers
US6528268B1 (en) 2001-08-03 2003-03-04 Sequenom-Gemini Limted Reagents and methods for detection of heart failure
US8021695B2 (en) * 2002-02-15 2011-09-20 Arch Personal Care Products, L.P. Personal care composition containing leghemoglobin
US20040081653A1 (en) 2002-08-16 2004-04-29 Raitano Arthur B. Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
NZ591879A (en) * 2003-10-23 2012-11-30 Kineta Two Llc Detection of mutations in a gene associated with resistance to viral infection, OAS1
EP2267154A1 (en) 2003-10-23 2010-12-29 Illumigen Biosciences, Inc. Oligoadenylate synthetase
US20060063184A1 (en) * 2004-09-09 2006-03-23 Felix Carolyn A Compositions and methods for the detection of DNA topoisomerase II complexes with DNA
UA95446C2 (en) * 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Mutations in oas1 genes
US20090269744A1 (en) * 2005-10-28 2009-10-29 Exonhit Therapeutics Sa Cancer detection method
FR2892730A1 (en) * 2005-10-28 2007-05-04 Biomerieux Sa Detecting the presence/risk of cancer development in a mammal, comprises detecting the presence/absence or (relative) quantity e.g. of nucleic acids and/or polypeptides coded by the nucleic acids, which indicates the presence/risk
WO2008058018A2 (en) 2006-11-02 2008-05-15 Mayo Foundation For Medical Education And Research Predicting cancer outcome
EP2806054A1 (en) 2008-05-28 2014-11-26 Genomedx Biosciences Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
CN103403181B (en) 2010-11-19 2016-09-07 密执安大学评议会 NcRNA and application thereof
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
EP2791359B1 (en) 2011-12-13 2020-01-15 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
EP3435084B1 (en) 2012-08-16 2023-02-22 Decipher Biosciences, Inc. Prostate cancer prognostics using biomarkers
CN110506127B (en) 2016-08-24 2024-01-12 维拉科特Sd公司 Use of genomic tags to predict responsiveness of prostate cancer patients to post-operative radiation therapy
AU2018210695A1 (en) 2017-01-20 2019-08-08 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018165600A1 (en) 2017-03-09 2018-09-13 Genomedx Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11078542B2 (en) 2017-05-12 2021-08-03 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
CN110117619B (en) * 2018-02-05 2022-10-11 中国科学院分子植物科学卓越创新中心 Method for preparing male sterile line of diamondback moth and nucleic acid thereof
CN110835651B (en) * 2018-08-17 2021-07-30 河南农业大学 Primer and kit for detecting indel multiple allele markers of chicken CDKN3 gene promoter region and application of primer and kit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011220A2 (en) * 1996-09-12 1998-03-19 Incyte Pharmaceuticals, Inc. Novel human cell division cycle proteins
WO2001002568A2 (en) * 1999-07-02 2001-01-11 Chiron Corporation Human genes and gene expression products

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998011220A2 (en) * 1996-09-12 1998-03-19 Incyte Pharmaceuticals, Inc. Novel human cell division cycle proteins
WO2001002568A2 (en) * 1999-07-02 2001-01-11 Chiron Corporation Human genes and gene expression products

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 22 January 2001 (2001-01-22), DIAS NETO E. ET AL.: "QV2-NT0147-191100-484-a09 NT0147 Homo sapiens cDNA, mRNA sequence.", XP002179205 *
DATABASE EMBL 23 August 1997 (1997-08-23), RAMSAY, H.: "Human DNA sequence from clone RP1-138B7 on chromosome 20q13.12 Contains the 3' end of the gene for a Drosophila lethal (3) malignant brain tumor (l(3)mbt) protein homolog (KIAA0681, DFKZp586P1522), the SGK2 gene for serum/glucocorticoid regulated kinase 2, the 5' end of the gene for CGI-53 .....", XP002179201 *
DATABASE EMBL 26 May 2000 (2000-05-26), DIAS NETO E. ET AL.: "RC0-NN0054-110400-021-e04 NN0054 Homo sapiens cDNA, mRNA sequence.", XP002179204 *
DIAS NETO E ET AL: "shotgun sequencing of the human transcriptome with ORF expressed sequence tags", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 97, no. 7, 28 March 2000 (2000-03-28), pages 3491 - 3496, XP002138179, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1263956A2 (en) 2002-12-11
AU2001245619A1 (en) 2001-09-17
US20030044783A1 (en) 2003-03-06
JP2004502406A (en) 2004-01-29
WO2001066753A2 (en) 2001-09-13

Similar Documents

Publication Publication Date Title
WO1999038972A3 (en) Human genes and gene expression products ii
WO1999058675A3 (en) Human genes and gene expression products v
WO2002014500A3 (en) Human genes and gene expression products
WO2001066753A3 (en) Human genes and gene expression products
WO1999033982A3 (en) Human genes and gene expression products i
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
WO2000040614A3 (en) Characterization of the soc/crac calcium channel protein family
WO2002029086A3 (en) Nucleic acid sequences differentially expressed in cancer tissue
WO2002008285A3 (en) Il-17 molecules and uses thereof
WO2001005825A3 (en) Nucleic acid sequences encoding putative angiopoietin proteins
WO2002044320A3 (en) Human elongase genes and uses thereof
WO1999064594A8 (en) Genes and gene expression products that are differentially regulated in prostate cancer
WO2001068705A3 (en) Il-17 receptor like molecules and uses thereof
WO2001064877A3 (en) Human schizophrenia gene
WO2003050236A3 (en) Human genes and gene expression products isolated from human prostate
WO2000018916A3 (en) Human genes and gene expression products
WO2001072781A3 (en) Human genes and expression products
WO2001064876A3 (en) Human schizophrenia gene
WO2001059120A3 (en) Il-17 like molecules and uses thereof
WO2001014415A3 (en) Egfh2 genes and gene products
WO2002055700A3 (en) Human genes and gene expression products isolated from human prostate
WO2002070563A3 (en) Nuclear hormone receptor ligand binding domain
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
EP1329504A4 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2001000662A3 (en) The use of human fgh-8 polypeptides as neurotrophic agents

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001918557

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001918557

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001918557

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)